|Bloom, Burton & Co.||Dave Martin, PhD|
|GMP Securities L.P.||Justin Keywood|
HLS Therapeutics is followed by the analysts indicated above. The opinions, estimates or forecasts made by these analysts do not reflect the opinions, estimates or forecasts of HLS or its management. By referring to the analyst indicated above, HLS in no way endorses these opinions, estimates and forecasts.